WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (192)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Matsuki, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Matsuki, N.

 Previous Article  |  Next Article 

Volume 17, Number 9, Issue of May 1, 1997 pp. 2959-2966
Copyright ©1997 Society for Neuroscience

Inhibition of GABAA Synaptic Responses by Brain-Derived Neurotrophic Factor (BDNF) in Rat Hippocampus

Tatsuro Tanaka, Hiroshi Saito, and Norio Matsuki

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113, Japan

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Brain-derived neurotrophic factor (BDNF) is one of neurotrophins involved in the development and maintenance of both the peripheral nervous system and CNS. Although the expression of BDNF and its receptor TrkB still occurs in the adult stage, their physiological role in the mature CNS is not fully understood. In the present study we examined in detail the possibility that BDNF modulates synaptic neurotransmissions by using patch-clamp technique in rat hippocampal CA1 region. BDNF (20-100 ng/ml) did not show any appreciable effect on evoked EPSCs, but it markedly reduced both evoked and spontaneous IPSCs within 5 min, and the reduction persisted while BDNF was present. BDNF also attenuated GABAA receptor-mediated response to applied GABA. However, BDNF failed to attenuate IPSCs when the postsynaptic pyramidal neuron was loaded intracellularly with 200 nM K252a, an alkaloid that inhibits the kinase activity of Trk receptor family, through the patch pipette. Intracellular application of 200 nM K252b, a weaker inhibitor of Trk-type kinase, did not affect the inhibition. The attenuating effect also was prevented by postsynaptic injection of U73122 (5 µM), a broad-spectrum PLC inhibitor, and by strong chelation of intracellular Ca2+ with 10 mM BAPTA. These data suggest that BDNF modulates GABAA synaptic responses by postsynaptic activation of Trk-type receptor and subsequent Ca2+ mobilization in the CNS.

Key words: BDNF; GABAA receptor; disinhibition; plasticity; LTP; hippocampus

INTRODUCTION

Brain-derived neurotrophic factor (BDNF) is one of the neurotrophins involved in the development and maintenance of both the peripheral nervous system and CNS. During brain development neurotrophins and their receptors display distinct stage- and tissue-specific patterns of expression (Ernfors et al., 1990a; Phillips et al., 1990; Merlio et al., 1992). BDNF mRNA is observed in the embryonic stage and is still present in the postnatal and adult stages (Ernfors et al., 1990b; Maisonpierre et al., 1990; Freidman et al., 1991). In the adult stage its expression level is modulated dramatically by neuronal activity (Falkenberg et al., 1992; Patterson et al., 1992; Rocamora et al., 1992; Bengzon et al., 1993; Kokaia et al., 1993). Moreover, expression of TrkB, a functional BDNF receptor, not only increases during embryonic development but also continues to increase until several weeks after birth in the hippocampus (Masana et al., 1993; Ringstedt et al., 1993). These observations suggest that in the adult CNS dynamic change in BDNF level still can trigger neuronal plasticity via activation of TrkB. Indeed, neurotrophins are secreted by neurons in both a constitutive and an activity-dependent manner (Blöchl and Thoenen, 1995, 1996; Griesbeck et al., 1995; Thoenen, 1995; Goodmann et al., 1996). Additionally, BDNF induces long-lasting enhancement of synaptic transmission (Kang and Schuman, 1995) and facilitates the induction of long-term potentiation (LTP) in the hippocampus (Figurov et al., 1996); however, the site and mechanism of action of BDNF remain unclear, because the effect of BDNF on synaptic transmission has been assessed by analyzing field (extracellular) potential changes in most cases. In the present study we examined in detail the possibility that BDNF regulates synaptic neurotransmissions by using the patch-clamp technique in rat hippocampal CA1 region and have presented evidence that BDNF directly modulates GABAA synaptic responses by postsynaptic activation of Trk-type receptor and subsequent Ca2+ mobilization in the CNS.

MATERIALS AND METHODS

Slice preparation. Male Wistar rats, 12-18 d old, were used to prepare 250-µm-thick hippocampal slices in ice-cold artificial cerebrospinal fluid (ACSF). Rats were decapitated, and the brains were removed. Transverse hippocampal slices were cut with a vibratome. Slices were incubated at room temperature (22-25°C) in ACSF oxygenated with 95% O2 and 5% CO2 in a holding chamber at least for 1 hr. Then they were plated in the recording chamber under a platinum-supported nylon mesh and perfused at a rate of 2 ml/min with ACSF at room temperature. ACSF was composed of (in mM): NaCl 124, NaHCO3 26, KCl 2, KH2PO4 1.24, MgSO4 5, CaCl2 2, glucose 10, and ascorbic acid 0.4.

Electrophysiological recordings. Whole-cell patch-clamp recordings were performed with a blind approach. Patch electrodes (2-4 MOmega ) were fabricated from borosilicate glass. The pipette solution contained (in mM): CsCl 140, CaCl2 0.2, EGTA 2, NaGTP 0.4, MgATP 4, and HEPES 10, pH 7.2 with CsOH. In some experiments 10 mM BAPTA and 125 mM CsCl were substituted for 2 mM EGTA and 140 mM CsCl, respectively. Chloride was used as a permeant anion in the internal solution to reverse the polarity and increase the amplitude of GABAA receptor-mediated IPSCs. Lidocaine N-ethyl bromide (QX314, 5 mM; Research Biochemicals, Natick, MA) also was included in the recording electrode solution to prevent depolarizing IPSCs from triggering action potentials. Voltage-clamp (-60 mV) recordings from hippocampal CA1 pyramidal cells were obtained with an Axoclamp 1D amplifier, data were digitized by a TL-1 DMA interface, and acquisition and analysis were performed with the pCLAMP computer program (Axon Instruments, Foster City, CA). The series resistance (usually 10-25 MOmega ) was monitored throughout the experiment; if it changed significantly, the experiment was rejected. Evoked EPSCs were obtained by stimulation of the Schaffer collateral-commissural afferents every 20 sec with bipolar tungsten electrodes in the presence of 20 µM picrotoxin to block inhibitory inputs. In most cases evoked monosynaptic IPSCs were obtained by stratum pyramidal (SP) stimulation at 0.1 Hz in the presence of 20 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 µM 2-amino-5-phosphonovaleric acid (APV) to block excitatory inputs. Stable recordings of PSCs usually were obtained 20-30 min after the rupture of the patch and continued for at least 30 min. In gramicidin perforated-patch recordings another pair of stimulating electrodes was positioned within 500 µm from the recording electrode in the stratum lacunosum-moleculare (SL-M) to obtain another type of GABAA-mediated IPSCs (Pearce, 1993). IPSCs recorded for every 2 min were averaged for evaluation of their amplitude.

Gramicidin perforated-patch recording. In simultaneous recording of two types of IPSCs, we used the gramicidin perforated-patch method. The antibiotic gramicidin (Sigma, St. Louis, MO), when incorporated into lipid membranes, forms pores that are permeable to monovalent cations and small uncharged molecules. This method can avoid diffusion of cytoplasmic factors out of the recorded neuron and disturbance of intrinsic intracellular Cl- concentration. It is particularly important to avoid the latter problem to gain stable and long-lasting recordings of IPSCs generated at synapses distant from soma, such as IPSCs evoked by SL-M stimulation, because physiologically excess Cl- in the pipette does not distribute quickly to dendrites. The internal solution for gramicidin recordings was prepared according to the methods reported previously (Kyrozis and Reichling, 1995). Briefly, before each perforated-patch experiment gramicidin (2 mg/ml) was dissolved in dimethyl sulfoxide (DMSO). The gramicidin-DMSO solution was added to the electrode solution (composed of 150 mM KCl and 10 mM HEPES, pH 7.2 with KOH) to give a final concentration of 5 µg/ml. In filling the electrode with gramicidin-containing solution, we usually omitted the process of tip prefilling with gramicidin-free solution because in our cases we encountered no significant difficulty in seal formation.

Reagents. Human recombinant BDNF was dissolved (100 µg/ml) in phosphate buffer containing 0.1% BSA and stored at -30°C. Before every experiment the stock solution was diluted with ACSF to the final concentration (20-100 ng/ml). Therefore, all experiments were performed in ACSF containing 0.0001% BSA, which did not have any detectable effect on EPSCs or IPSCs. K252a, K252b (Kyowa Medex, Tokyo, Japan), and U73122 (Biomol Research Lab, Plymouth Meeting, PA) were dissolved in DMSO. The final concentration of DMSO, 0.1% in bath-applied ACSF or 0.05% in patch-pipette solution, did not have any significant effect on synaptic responses.

RESULTS

Modulative effect of BDNF on IPSCs without affecting EPSCs

CA1 pyramidal neurons are innervated by fast excitatory synaptic inputs from the CA3 region. Stimulation of Schaffer collaterals produced non-NMDA-type (CNQX-sensitive) glutamate receptor-mediated EPSCs in voltage-clamped (-60 mV) CA1 pyramidal cells in whole-cell recordings in the presence of a GABAA receptor antagonist, bicuculline (20 µM; see Fig. 2A). On the other hand, they are also under inhibitory innervation of neighboring interneurons. SP stimulation, in the presence of 50 µM APV and 20 µM CNQX to block glutamatergic inputs, produced bicuculline- and picrotoxin-sensitive GABAA receptor-mediated inward-directed IPSCs (Fig. 1A). BDNF (20-100 ng/ml) showed no apparent effects on the amplitude of evoked EPSCs (mean ± SEM; % of baseline, 90.5 ± 7.9; n = 6) (Fig. 2B,C). However, the amplitude of evoked IPSCs was reduced markedly within 5 min after the start of BDNF perfusion, and this reduction persisted while BDNF was present (Fig. 1B,C). The attenuating effect of BDNF was concentration-dependent [mean ± SEM; % of baseline: BDNF 20 ng/ml, 70.9 ± 6.9 (n = 6), p < 0.05; 100 ng/ml, 55.6 ± 9.9 (n = 6), p < 0.05]. Although we did not analyze the recovery of the amplitude of IPSCs systematically, the washout of BDNF resulted in the recovery of the amplitude (>80% of the baseline response) in 5 of 12 neurons within 30 min. The reduced IPSCs did not recover in the rest of the neurons. In several cases we observed transient increases in the amplitude of IPSCs as well as that of EPSCs within 2 min after the start of 100 ng/ml BDNF perfusion (Figs. 1C, 2C). This enhancement was accompanied by an increase in the frequency of spontaneous postsynaptic currents (data not shown), although it was not statistically significant.
Fig. 2. BDNF did not affect non-NMDA-type glutamate receptor-mediated EPSCs. A, Recording of the CNQX-sensitive EPSCs from voltage-clamped (-60 mV) CA1 pyramidal neurons. Stimulation of Schaffer collaterals produced the inward currents sensitive to 20 µM CNQX in the presence of 20 µM bicuculline. Representative traces are shown as the average of eight consecutive responses (calibration: 25 pA, 30 msec). B, Effect of BDNF on evoked EPSCs. BDNF (100 ng/ml, 15 min) did not significantly affect non-NMDA-type glutamate receptor-mediated EPSCs (right). Each trace represents the averaged EPSCs of eight consecutive sweeps (calibration: 40 pA, 30 msec). C, The time courses of changes in EPSCs. BDNF tended to increase the amplitude of EPSCs transiently (within 2 min) but had no significant effect on subsequent EPSCs. Data are indicated as mean ± SEM (n = 6).
[View Larger Version of this Image (18K GIF file)]

Fig. 1. BDNF attenuated GABAA-mediated IPSCs in CA1 pyramidal cells. A, Recording of the bicuculline-sensitive IPSCs from voltage-clamped (-60 mV) CA1 pyramidal neurons in the whole-cell mode. Electrical stimulation of the stratum pyramidal generates the inward currents in the presence of glutamate receptor blockers APV (50 µM) and CNQX (20 µM). The inward currents were blocked completely by a GABAA-receptor antagonist bicuculline (20 µM) (left traces). The right trace is the recovery after a 20 min wash of bicuculline (calibration: 100 pA, 50 msec). B, Effect of BDNF on evoked IPSCs. Bath-applied BDNF (100 ng/ml, 15 min) dramatically reduced the amplitude of IPSCs. Two representative IPSCs (left) are from the time points indicated in C. In this neuron IPSCs recovered almost completely after a 30 min washout of BDNF (right). Each trace represents the averaged IPSCs of eight consecutive sweeps (calibration: 100 pA, 50 msec). C, The time courses of inhibition of the amplitude of IPSCs. Perfusion of BDNF (indicated as a horizontal solid bar) significantly reduced the amplitude of IPSCs (solid circles, 20 ng/ml; solid squares, 100 ng/ml; #p < 0.05, *p < 0.05, **p < 0.01, Dunnett test; n = 5-7). Data are indicated as mean ± SEM normalized to the amplitudes at the time point just before the application of BDNF.
[View Larger Version of this Image (18K GIF file)]

Modulation of two types of inhibitory inputs

To confirm the suppressive effect of BDNF on IPSCs, we used the gramicidin-perforated patch-clamp technique (Kyrozis and Reichling, 1995), which avoids diffusion of cytoplasmic factors out of the recorded neuron and disturbance of intracellular Cl- concentration. CA1 pyramidal neurons receive inhibitory inputs from two sources, SP and SL-M. The two GABAA-mediated inhibitory responses are distinct in terms of physiological, pharmacological, and anatomical properties (Pearce, 1993; Pearce et al., 1995). Stimulation of either SP or SL-M evoked GABAA-mediated IPSCs in the perforated mode. The reversal potential of IPSCs evoked by SP or SL-M stimulation was 72.6 ± 4.6 or 75.8 ± 4.9 mV, respectively (n = 6). Therefore, each type of IPSCs was recorded as outward-directed currents when cells were voltage-clamped at -50 mV (Fig. 3A). In the perforated mode, once adequate access resistance (<30 MOmega ) was achieved, we could obtain stable and long-lasting recordings of IPSCs for at least 1 hr. One of the typical simultaneous recordings of SP-evoked and SL-M-evoked IPSCs from the same neuron is shown in Figure 3. Application of 100 ng/ml BDNF silenced both types of IPSCs (Fig. 3B). In the perforated mode we could obtain similar results to those observed in the whole-cell mode. The reproducibility of the gramicidin-perforated mode confirmed that the attenuating effect of BDNF was not caused by experimental artifacts of the whole-cell mode.
Fig. 3. Attenuation of two distinct types of inhibitory inputs to CA1 pyramidal neurons by BDNF in the gramicidin perforated-patch method. A, Stimulation of the stratum pyramidal (SP stim.) and the stratum lacunosum-moleculare (SL-M stim.) produced distinct types of outward-directed IPSCs in the same CA1 pyramidal cell voltage-clamped at -50 mV. In this mode BDNF (100 ng/ml) also reduced both types of IPSCs. The representative traces are from the time points indicated in B. B, The typical time courses of reduction of the amplitude of IPSCs generated by stimulation of two sources, SP (open circles) and SL-M (solid circles). BDNF at 100 ng/ml (horizontal solid bar) silenced both types of inhibitory inputs. Data are plotted as the mean of eight IPSCs evoked by alternative stimulation of SP or SL-M in the same neuron.
[View Larger Version of this Image (18K GIF file)]

Involvement of a postsynaptic Trk-type receptor

BDNF specifically binds to TrkB, a neurotrophin receptor, including the catalytic domain of tyrosine kinase. When hippocampal slices were pretreated extracellularly with 200 nM K252a, an alkaloid that inhibits the kinase activity of the Trk receptor family (Knüsel and Hefti, 1992), BDNF failed to reduce the amplitude of IPSCs (Fig. 4A, solid squares), suggesting that BDNF requires Trk-type receptor activation for the depression of IPSCs. Attenuation of the amplitude of IPSCs by BDNF also was prevented when the postsynaptic pyramidal neuron was loaded intracellularly with K252a by use of a patch pipette containing 200 nM K252a (Fig. 4A, open squares), although it was not inhibited by intracellularly applied 200 nM K252b (Fig. 4C), which is a weaker kinase inhibitor of Trk-type [mean ± SEM; % of baseline: extracellular (ext) K252a, 90.2 ± 10.6 (n = 5); intracellular (int) K252a, 88.5 ± 13.0 (n = 5); int K252b, 61.6 ± 6.1 (n = 4), p < 0.05]. These data suggest that BDNF modulates IPSCs via activation of a postsynaptic Trk-type receptor.
Fig. 4. BDNF-induced inhibition of IPSCs requires postsynaptic activation of Trk-type receptor and subsequent Ca2+ mobilization. A, Perfusion of 100 ng/ml BDNF (horizontal solid bar) decreased the amplitude of IPSCs (open circles). Incubation of slices extracellularly with 200 nM K252a for 1 hr before the experiment prevented the 100 ng/ml BDNF-induced inhibition of IPSCs (solid squares). BDNF (100 ng/ml) also failed to attenuate IPSCs when CA1 pyramidal neurons were loaded intracellularly with 200 nM K252a (open squares) or 5 µM U73122 (solid triangles) in the whole-cell recording electrode. B, Intracellular BAPTA (10 mM) also blocked the 100 ng/ml BDNF-induced attenuation of IPSCs (open circles). Solid circles indicate control responses in the absence of BDNF. C, Summarized graph from A. Data are ensemble averages measured between 8 and 14 min after the application of BDNF. Extracellular application (ext) of 200 nM K252a and intracellular application (int) of 200 nM K252a and 5 µM U73122 effectively prevented the attenuation by BDNF. Intracellular K252b (200 nM) was ineffective (**p < 0.01, Dunnett test; n = 5-6).
[View Larger Version of this Image (27K GIF file)]

Involvement of [Ca2+]i mobilization

In hippocampal pyramidal neurons phospholipase C-gamma 1 (PLC-gamma 1) is abundant in the cell soma as well as in dendrites (Yamada et al., 1991). This enzyme, activated by TrkB, generates inositol triphosphate (IP3), which mobilizes intracellular Ca2+ from endoplasmic reticulum (Widmer et al., 1992, 1993; Zirrgiebel et al., 1995). Thus, we investigated the possibility of involvement of intracellular Ca2+ mobilization. BDNF failed to attenuate IPSCs when U73122 (5 µM), a broad-spectrum PLC inhibitor (Chen et al., 1994), was injected intracellularly into pyramidal neurons (Fig. 4A, solid triangles) [mean ± SEM; % of baseline: int U73122, 84.3 ± 4.4 (n = 5)] or when intracellular Ca2+ concentration ([Ca2+]i) was reduced with 10 mM BAPTA, a potent chelator (Fig. 4B) [mean ± SEM; % of baseline: control, 101.8 ± 7.6 (n = 7); BDNF 20 ng/ml, 97.1 ± 8.4 (n = 5); BDNF 100 ng/ml, 97.7 ± 3.7 (n = 7)]. These data suggest that BDNF reduces the amplitude of IPSCs by postsynaptic elevation of [Ca2+]i via IP3 production.

Reduction of postsynaptic responsiveness to applied GABA

As mentioned above, we found that the second messenger system in postsynaptic neurons is necessary for the reduction of IPSCs. However, whether postsynaptic Trk activation results in a decrease of postsynaptic GABAA receptor responsiveness or in attenuation of presynaptic GABA release remains to be clarified. Metabotropic change in postsynaptic cells may influence presynaptic GABA release. Previous works (Pilter and Alger, 1992, 1994) indicate that an increase in postsynaptic [Ca2+]i induced by spike firing or depolarization reduces GABAergic synaptic inhibition by decreasing the release of GABA presynaptically. Therefore, we analyzed the inhibitory effect of BDNF on the responsiveness to applied GABA.

GABA was applied to a hippocampal slice by gravity-driven flow through a multibarreled tube (diameter 1.5 mm) positioned <200 µm from the recorded CA1 pyramidal neuron. Introduction of 10 µM GABA for 2 sec at the CA1 region at 3 or 5 min intervals induced GABAA receptor-mediated inward current. Because GABA was applied for only 2 sec, no apparent desensitization or running-down of the responses was observed at these intervals for at least 30 min [96.4 ± 4.8% (n = 4) of the initial control response]. Bath application of 50 ng/ml BDNF for 15 min decreased GABA-induced current to 64.4 ± 8.8% (n = 4) of the control response before treatment (Fig. 5). This suggests that BDNF reduces postsynaptic responsiveness to GABA.

Fig. 5. Reduction of postsynaptic responsiveness to GABA. Gravity-driven introduction of 10 µM GABA for 2 sec (horizontal solid bars) at 5 min intervals through a multibarreled tube positioned <200 µm from the CA1 region elicited inward-directed GABAA receptor-mediated current in voltage-clamped (-60 mV) CA1 pyramidal cells (left). This response was attenuated by a 15 min perfusion of 50 ng/ml BDNF (middle). More than 30 min of washout of BDNF was necessary for the recovery (right), but it was incomplete.
[View Larger Version of this Image (15K GIF file)]

Effects on spontaneous IPSCs

Experiments on stimulus-evoked IPSCs were supplemented with data on spontaneous events that result from action potentials generated by interneurons, because these events probably reflect accurately the normal functioning of GABA synapses (Mody et al., 1994). Numerous spontaneously occurring currents were recorded from CA1 pyramidal neurons in the presence of 50 µM APV and 20 µM CNQX. They were blocked by 10 µM picrotoxin or bicuculline, indicating that they are IPSCs generated by spontaneous GABA release from interneurons (Fig. 6). Perfusion of a hippocampal slice with BDNF (50 ng/ml) for 15 min markedly reduced the size of the events (Fig. 7A) and caused a significant decrease in the average amplitude of IPSCs (control, 32.7 ± 10.2 pA; BDNF, 23.9 ± 9.9 pA; p < 0.01, paired t test; n = 5), although the total frequency was not changed significantly (control, 2.85 ± 0.62 Hz; BDNF, 2.56 ± 0.77 Hz). This decrease of the mean amplitude resulted in a leftward shift in the amplitude distribution (Fig. 7B).
Fig. 6. Recording of spontaneous IPSCs from CA1 pyramidal cells. A, Numerous spontaneous events were recorded from voltage-clamped (-60 mV) CA1 pyramidal cells in the presence of 50 µM APV and 20 µM CNQX. B, Bicuculline (20 µM), a GABAA receptor antagonist, completely blocked the spontaneous events. C, Shown is the recovery of the spontaneous events after the washout of bicuculline.
[View Larger Version of this Image (21K GIF file)]

Fig. 7. Reduction of the amplitude, but not the frequency, of spontaneous IPSCs by BDNF. BDNF (50 ng/ml, 15 min) reduced the amplitude, but not the frequency, of spontaneous IPSCs (lower traces). B, Summarized histograms from the data shown in A. BDNF caused a slight leftward shift in the amplitude distribution, reflecting a decrease in the mean size of these events. Data were sampled for 200 sec in the absence (left) or presence (right) of 50 ng/ml BDNF.
[View Larger Version of this Image (23K GIF file)]

DISCUSSION

Inhibition of GABAA receptor-mediated IPSCs by BDNF

The present experiments demonstrated that BDNF regulates GABAA receptor responses via activation of a Trk-type receptor located in postsynaptic neurons. In the hippocampus excitatory neuronal networks are controlled by inhibitory innervation. An anatomical and electrophysiological approach identified three distinct types of GABAergic neurons (axo-axonic, basket, and bistratified cells) in the hippocampus. Each type of inhibitory neuron innervates a different domain of the surface of the principal neurons by activation of postsynaptic GABAA receptor. The axo-axonic cell primarily forms synapses on the axon initial segment of the principal cell, the basket cell primarily on the soma, and the bistratified cell on the apical and basal dendrites (Buhl et al., 1994). GABAergic interneurons mediate different inhibitory effects, such as recurrent inhibition, shunting of dendritic excitatory inputs, or governing of the firing threshold. Therefore, suppression of postsynaptic GABAA receptor by BDNF will facilitate neural excitation and generation of action potential firing. Indeed, exogenous BDNF promotes the induction of LTP in the young hippocampus; in turn, endogenous BDNF is suggested to be involved in the triggering mechanism of LTP in the adult (Figurov et al., 1996). Disinhibition induced by BDNF will participate in the induction of LTP, because elimination of GABAergic hyperpolarizing influence relieves voltage-dependent Mg2+ block of NMDA receptor-channel and facilitates the induction of LTP (Davies et al., 1991; Mott and Lewis, 1991). This also is supported by the results of mutant mice lacking BDNF (Korte et al., 1995), which showed significantly reduced LTP in the hippocampus. Moreover, judging from the figure, field EPSP of the mutant mice clearly was enhanced more by GABAA-receptor blocker than that of control mice, although the authors did not mention it. This result agrees with our data that BDNF suppresses GABAA synaptic responses. GABAA-mediated synaptic transmission in the normal hippocampus may be regulated adequately by endogenous BDNF.

Kim et al. (1994) reported previously that neurotrophin-3 (NT-3), another member of neurotrophins, inhibits GABAA synaptic transmission in cultured embryonic cortical neurons. NT-3 primarily binds to TrkC but also can activate TrkB (Soppet et al., 1991; Squinto et al., 1991). Therefore, it was not clear whether TrkB participates in the regulation of GABAA receptor function. The present study using BDNF, a specific ligand for TrkB, indicates that TrkB participates in the modulation of GABAA receptor function, although TrkC also may regulate it. However, in contrast to BDNF expression, NT-3 expression level is downregulated in the adult brain by neuronal activity (Lindvall et al., 1992; Rocamora et al., 1992, 1994; Bengzon et al., 1993) (but also see Patterson et al., 1992). In this respect, it is difficult to regard NT-3 as a signal that is secreted activity dependently, which triggers neural plasticity. BDNF seems to be a more promising candidate for the signal because of its mRNA upregulation (Falkenberg et al., 1992; Patterson et al., 1992; Rocamora et al., 1992; Bengzon et al., 1993; Kokaia et al., 1993) and secretion by neuronal activity (Griesbeck et al., 1995; Goodmann et al., 1996). Generally, expression of NT-3 is highest in immature CNS and dramatically decreases with maturation. On the contrary, expression of BDNF is low in developing regions of the CNS and increases as these regions mature (Maisonpierre et al., 1990). Therefore, TrkC activated by NT-3 may modulate synaptic transmission in the developing synapses, but not in the matured synapses.

BDNF did not affect non-NMDA-type glutamate receptor-mediated EPSCs in the present study. However, Levine et al. (1995) reported that BDNF increased both the frequency and amplitude of excitatory transmission in cultured embryonic neurons. Two contradictory results were reported from the analysis of field potentials in hippocampal slices. Kang and Schuman (1995) showed long-lasting BDNF-induced enhancement of synaptic transmission, whereas Figurov et al. (1996) recently reported no change of baseline response. We do not have a reasonable explanation for the discrepancy; however, Kang et al. (1996) reported that the perfusion rate is critical for the penetration of BDNF into the hippocampal slices.

In several cases we observed transient increases in the amplitude of EPSCs as well as that of IPSCs within 2 min after the start of BDNF perfusion (Fig. 1B,D), although it was not statistically significant. This enhancement was accompanied by an increase in frequency of spontaneous postsynaptic currents, which was similar to the results in cultured embryonic neurons (Lebeta mann et al., 1994). The transient effect is probably attributable to the presynaptic enhancement, because the intracellular application of K252a or BAPTA into postsynaptic neurons did not affect it.

Modulation of two types of inhibitory inputs

CA1 pyramidal neurons receive GABAA receptor-mediated inhibitory inputs from two sources, SP and SL-M. The two GABAA-mediated inhibitory responses are distinct in term of physiological, pharmacological, and anatomical properties (Pearce, 1993; Pearce et al., 1995). However, BDNF inhibited both IPSCs evoked by SP and SL-M stimulations, suggesting the colocalization of GABAA receptor and BDNF receptor TrkB. TrkB immunoreactivity is distributed widely to the pyramidal cell soma and dendrites (Zhou et al., 1993). Additionally, PLC-gamma 1 also is distributed widely and abundantly in the pyramidal cell (Yamada et al., 1991) in correspondence to the wide distribution of TrkB, suggesting the functional coupling between GABAA receptor and TrkB signaling cascade.

Involvement of postsynaptic TrkB activation

BDNF specifically binds to TrkB, a neurotrophin receptor, including the catalytic domain of tyrosine kinase (Soppet et al., 1991; Squinto et al., 1991). BDNF failed to reduce the amplitude of IPSCs when the recorded neuron was loaded intracellularly with K252a as well as when hippocampal slices were pretreated with K252a. K252a is an alkaloid that inhibits biological activities of neurotrophins and kinase activity of the Trk receptor family (Knüsel and Hefti, 1992). Therefore, these data suggest that BDNF modulates IPSCs via activation of a postsynaptic Trk-type receptor. K252b (200 nM) could not inhibit BDNF-induced reduction in the amplitude of IPSCs. It is a weaker inhibitor and is usually effective at concentrations higher than 1 µM (Widmer et al., 1992).

Involvement of intracellular Ca2+ mobilization

The binding of neurotrophins to the Trk receptor family initiates a signaling cascade involving phosphorylation of intracellular proteins on tyrosine residues. BDNF-activated TrkB rapidly associates with and phosphorylates the cytoplasmic proteins, PLC-gamma 1, SUS-associated neurotrophic factor-induced tyrosine-phosphor-ylated target (SNT), and Erk1 (Knüsel et al., 1994). In hippocampal pyramidal neurons PLC-gamma 1 is abundant in the cell soma as well as in the dendrites (Yamada et al., 1991). This enzyme, activated by TrkB, generates inositol triphosphate (IP3), which mobilizes intracellular Ca2+ from endoplasmic reticulum (Widmer et al., 1992, 1993; Zirrgiebel et al., 1995). BDNF failed to attenuate IPSCs when U73122, a broad-spectrum PLC inhibitor (Chen et al., 1994), was injected intracellularly into pyramidal neurons (Fig. 3A, solid triangles) or when intracellular Ca2+ concentration ([Ca2+]i) was reduced with 10 mM BAPTA, a potent chelator (Fig. 3B). These data suggest that BDNF reduces the amplitude of IPSCs by postsynaptic elevation of [Ca2+]i via IP3 production. BDNF stimulates PLC-gamma 1 phosphorylation within 20 sec (Widmer et al., 1993) and mobilizes intracellular Ca2+ within 1 min (Berninger et al., 1993). In this respect, there seems to be a time lag between elevation of [Ca2+]i and BDNF-induced reduction of the amplitude of IPSCs, suggesting the involvement of activation of some signal cascade after the rise in [Ca2+]i. GABAA receptor function is maintained by phosphorylation and disrupted by [Ca2+]i elevation (Stelzer et al., 1988; Marchenko, 1991; Gyenes et al., 1994; Moss et al., 1995). In this respect, dephosphorylation induced by a Ca2+-dependent phosphatase may be involved in the downstream of BDNF-activated signal transduction and lead to the attenuation of GABAA response (Stelzer and Shi, 1994; Chen and Wong, 1995).

Reduction in the amplitude of spontaneous IPSCs

BDNF reduced the amplitude of spontaneous IPSCs (sIPSCs), but not total frequency (Fig. 7). The spontaneous events that result from action potentials generated by interneurons probably reflect accurately the normal functioning of GABA synapse (Mody et al., 1994). These sIPSCs result from the highly synchronous release of GABA at several boutons, although stimulus-evoked IPSCs tends to reflect asynchronous release. Therefore, analysis of sIPSCs attributes the decrease of amplitude by BDNF to the reduction of postsynaptic receptor responsiveness to released GABA. This result coincides with the postsynaptic reduction of responses to exogenously applied GABA (Fig. 5) and also is supported by the pharmacological attempts to block postsynaptic Trk-type receptor kinase activity (Fig. 4).

Conclusion

The present study demonstrates that BDNF directly modulates GABAA function, but not glutamate receptor function, via postsynaptic activation of Trk-type receptors. This disinhibition would enhance synaptic responses and facilitate the induction of LTP by eliminating dendritic shunting. BDNF not only enhances synaptic efficacy but also may promote the transduction of output signal.

FOOTNOTES

Received Nov. 18, 1996; revised Feb. 3, 1997; accepted Feb. 11, 1997.

  

We thank Sumitomo Pharmaceutical Company for providing human recombinant BDNF and Dr. Hiroshi Katsuki for excellent technical advice.

Correspondence should be addressed to Dr. Norio Matsuki at the above address.


REFERENCES

  • Bengzon J, Kokaia Z, Ernfors P, Kokaia M, Leanza G, Nilsson OG, Persson H, Lindvall O (1993) Regulation of neurotrophin and trkA, trkB, and trkC tyrosine kinase receptor messenger RNA expression in kindling. Neuroscience 53:433-446[Web of Science][Medline].
  • Berninger B, García DE, Inagaki N, Hahnel C, Lindoholm D (1993) BDNF and NT-3 induce intracellular Ca2+ elevation in hippocampal neurons. NeuroReport 4:1303-1306[Web of Science][Medline].
  • Blöchl A, Thoenen H (1995) Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway. Eur J Neurosci 7:1220-1228[Web of Science][Medline].
  • Blöchl A, Thoenen H (1996) Localization of cellular storage compartments and sites of constitutive and activity-dependent release of nerve growth factor (NGF) in primary cultures of hippocampal neurons. Mol Cell Neurosci 7:173-190[Web of Science][Medline].
  • Buhl EH, Halasy K, Somogyi P (1994) Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature 368:823-828[Medline].
  • Chen P, Xie H, Sekar C, Gupta K, Wells A (1994) Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127:847-857[Abstract/Free Full Text].
  • Chen QX, Wong RKS (1995) Suppression of GABAA receptor responses by NMDA application in hippocampal neurons acutely isolated from the adult guinea-pig. J Physiol (Lond) 482:353-362[Abstract/Free Full Text].
  • Davies CH, Starkey SJ, Pozza MF, Collingridge GL (1991) GABAB autoreceptors regulate the induction of LTP. Nature 349:609-611[Medline].
  • Ernfors P, Ibáñez CF, Ebendal T, Olson L, Persson H (1990a) Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87:5454-5458[Abstract/Free Full Text].
  • Ernfors P, Wetmore C, Olson L, Persson H (1990b) Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5:511-526[Web of Science][Medline].
  • Falkenberg T, Ernfors P, Persson H, Lindefors N (1992) Cortical trans-synaptic activation of tyrosine kinase receptor trkB messenger RNA expression in rat hippocampus. Neuroscience 51:883-889[Web of Science][Medline].
  • Figurov A, Pozzo-Miller L, Olafsson P, Wang T, Lu B (1996) Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381:706-709[Medline].
  • Friedman WJ, Ernfors P, Persson H (1991) Transient and persistent expression of NT-3/HDNF mRNA in the rat brain during postnatal development. J Neurosci 11:1577-1584[Abstract].
  • Goodmann LJ, Valverde J, Lim F, Geschwind MD, Federoff HJ, Geller AI, Hefti F (1996) Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol Cell Neurosci 7:222-238[Web of Science][Medline].
  • Griesbeck O, Blöchl A, Carnahan JF, Nawa H, Thoenen H (1995) Characterization of brain-derived neurotrophic factor (BDNF) secretion from hippocampal neurons. Soc Neurosci Abstr 21[part 2]:1046.
  • Gyenes M, Wang Q, Gibbs TT, Farb DH (1994) Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma -aminobutyric acid type A receptor. Mol Pharmacol 46:542-549[Abstract].
  • Kang H, Schuman EM (1995) Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 264:1658-1662[Web of Science].
  • Kang H, Jia LZ, Suh KY, Tang L, Schuman EM (1996) Determination of BDNF-induced hippocampal synaptic plasticity: role of the TrkB receptor and the kinetics of neurotrophin delivery. Learn Mem 3:188-196.[Abstract/Free Full Text]
  • Kim HG, Wang T, Olafsson P, Lu B (1994) Neurotrophin 3 potentiates neuronal activity and inhibits gamma -aminobutyratergic synaptic transmission in cortical neurons. Proc Natl Acad Sci USA 91:12341-12345[Abstract/Free Full Text].
  • Knüsel B, Hefti F (1992) K252 compounds: modulators of neurotrophin signal transduction. J Neurochem 59:1987-1996[Web of Science][Medline].
  • Knüsel B, Rabin SJ, Hefti F, Kaplan DR (1994) Regulated neurotrophin receptor responsiveness during neural migration and early differentiation. J Neurosci 14:1542-1554[Abstract].
  • Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O (1993) Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci USA 90:6711-6715[Abstract/Free Full Text].
  • Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860[Abstract/Free Full Text].
  • Kyrozis A, Reichling DB (1995) Perforated-patch recording with gramicidin avoids artifactual changes in intracellular chloride concentration. J Neurosci Methods 57:27-35[Web of Science][Medline].
  • Lebeta mann V, Gottmann K, Heumann R (1994) BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurons. NeuroReport 6:21-25[Web of Science][Medline].
  • Levine ES, Dreyfus CF, Black IB, Plummer MR (1995) Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc Natl Acad Sci USA 92:8074-8077[Abstract/Free Full Text].
  • Lindvall O, Ernfors P, Bengzon J, Kokaia Z, Smith ML, Siesjö BK, Persson H (1992) Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 89:648-652[Abstract/Free Full Text].
  • Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME, Lindsay RM, Yancopoulos GD (1990) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5:501-509[Web of Science][Medline].
  • Marchenko SM (1991) Mechanism of modulation of GABA-activated current by internal calcium in rat central neurons. Brain Res 546:355-357[Web of Science][Medline].
  • Masana Y, Wanaka A, Kato H, Asai T, Tohyama M (1993) Localization of trkB mRNA in postnatal development. J Neurosci Res 35:468-479[Web of Science][Medline].
  • Merlio JP, Ernfors MJ, Persson H (1992) Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 51:513-532[Web of Science][Medline].
  • Mody I, Koninck D, Otis TS, Sotesz I (1994) Bridging the cleft at GABA synapses in the brain. Trends Neurosci 17:517-525[Web of Science][Medline].
  • Moss SJ, Gorrie GH, Amato A, Smart TG (1995) Modulation of GABAA receptors by tyrosine phosphorylation. Nature 377:344-348[Medline].
  • Mott DD, Lewis DV (1991) Facilitation of the induction of long-term potentiation by GABAB receptors. Science 252:1718-1720[Abstract/Free Full Text].
  • Patterson SL, Grover LM, Schwartzkroin PA, Bothwell M (1992) Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNA. Neuron 9:1081-1088[Web of Science][Medline].
  • Pearce RA (1993) Physiological evidence for two distinct GABAA responses in rat hippocampus. Neuron 10:189-200[Web of Science][Medline].
  • Pearce RA, Grunder SD, Faucher LD (1995) Different mechanisms for use-dependent depression of two GABAA-mediated IPSCs in rat hippocampus. J Physiol (Lond) 484:425-435[Abstract/Free Full Text].
  • Phillips HS, Hains HM, Laramee GR, Rosenthal A, Winslow A (1990) Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science 250:290-294[Abstract/Free Full Text].
  • Pilter TA, Alger BE (1992) Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12:4122-4132[Abstract].
  • Pilter TA, Alger BE (1994) Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G-protein involvement in a presynaptic mechanism. Neuron 13:1447-1455[Web of Science][Medline].
  • Ringstedt T, Lagercrantz H, Persson H (1993) Expression of members of the trk family in the developing postnatal rat brain. Dev Brain Res 72:119-131[Medline].
  • Rocamora N, Palacios JM, Mengod G (1992) Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the rat hippocampus. Mol Brain Res 13:27-33[Medline].
  • Rocamora N, Massieu L, Boddeke HWGM, Palacios JM, Mengod G (1994) Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 mRNAs in adult rat brain after intrahippocampal injection of quinolinic acid. Mol Brain Res 26:89-98[Medline].
  • Soppet D, Escandon D, Maragos J, Middlemas DS, Reid SW, Blair J, Burton LE, Stanton BR, Kaplan DR, Hunter T, Nikolics K, Parada LF (1991) The neurotrophic factors, brain-derived neurotrophic factor and neurotrophin-3, are ligands for the trkB tyrosine kinase receptor. Cell 65:895-903[Web of Science][Medline].
  • Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, Glass DJ, Masiakowski P, Furth ME, Valenzuela DM, DiStefano PS, Yancopoulos GD (1991) TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3, but not nerve growth factor. Cell 65:885-893[Web of Science][Medline].
  • Stelzer A, Shi H (1994) Impairment of GABAA receptor function by N-methyl-D-aspartate-mediated calcium influx in isolated CA1 pyramidal cells. Neuroscience 62:813-828[Web of Science][Medline].
  • Stelzer A, Kay AR, Wong RKS (1988) GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors. Science 241:339-341[Abstract/Free Full Text].
  • Stuart GJ, Sakmann B (1994) Active propagation of somatic action potentials into neocortical pyramidal cell dendrites. Nature 367:69-72[Medline].
  • Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270:593-598[Abstract/Free Full Text].
  • Widmer HR, Knüsel B, Hefti F (1992) Stimulation of phosphatidylinositol hydrolysis by brain-derived neurotrophic factor and neurotrophin-3 in rat cerebral cortical neurons developing in culture. J Neurochem 59:2113-2124[Web of Science][Medline].
  • Widmer HR, Kaplan DR, Rabin SJ, Beck KD, Hefti F, Knüsel B (1993) Rapid phosphorylation of phospholipase Cgamma 1 by brain-derived neurotrophic factor and neurotrophin-3 in cultures of embryonic rat cortical neurons. J Neurochem 60:2111-2123[Web of Science][Medline].
  • Yamada M, Mizuguchi M, Rhee SG, Kim SU (1991) Developmental changes of three phosphoinositide-specific phospholipase C isozymes in the rat nervous system. Dev Brain Res 59:7-16[Medline].
  • Zhou XF, Parada LF, Soppet D, Rush RA (1993) Distribution of TrkB tyrosine kinase immunoreactivity in the rat central nervous system. Brain Res 622:63-70[Web of Science][Medline].
  • Zirrgiebel U, Ohga Y, Carter B, Berninger B, Inagaki N, Thoenen H, Lindoholm D (1995) Characterization of TrkB receptor-mediated signaling pathways in rat cerebellar granule neurons: involvement of protein kinase C in neuronal survival. J Neurochem 65:2241-2250[Web of Science][Medline].
Copyright ©1997 Society for Neuroscience   0270-6474/1997/172959-08$05.00/0



This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Sakata, N. H. Woo, K. Martinowich, J. S. Greene, R. J. Schloesser, L. Shen, and B. Lu
Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex
PNAS, April 7, 2009; 106(14): 5942 - 5947.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
L. Pozzo-Miller
GABAergic synapse maturation: evidence of the instructive role of activity-dependent BDNF release
J. Physiol., November 1, 2008; 586(21): 5041 - 5041.
[Full Text] [PDF]

Home page
 J. Physiol.Home page
N. Kuczewski, A. Langlois, H. Fiorentino, S. Bonnet, T. Marissal, D. Diabira, N. Ferrand, C. Porcher, and J.-L. Gaiarsa
Spontaneous glutamatergic activity induces a BDNF-dependent potentiation of GABAergic synapses in the newborn rat hippocampus
J. Physiol., November 1, 2008; 586(21): 5119 - 5128.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. C. Fernandes, A. Pinto-Duarte, J. A. Ribeiro, and A. M. Sebastiao
Postsynaptic Action of Brain-Derived Neurotrophic Factor Attenuates {alpha}7 Nicotinic Acetylcholine Receptor-Mediated Responses in Hippocampal Interneurons
J. Neurosci., May 21, 2008; 28(21): 5611 - 5618.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
I. Abidin, U. T. Eysel, V. Lessmann, and T. Mittmann
Impaired GABAergic inhibition in the visual cortex of brain-derived neurotrophic factor heterozygous knockout mice
J. Physiol., April 1, 2008; 586(7): 1885 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
S. Lei, P.-Y. Deng, J. E. Porter, and H.-S. Shin
Adrenergic Facilitation of GABAergic Transmission in Rat Entorhinal Cortex
J Neurophysiol, November 1, 2007; 98(5): 2868 - 2877.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
Y. Ben-Ari, J.-L. Gaiarsa, R. Tyzio, and R. Khazipov
GABA: A Pioneer Transmitter That Excites Immature Neurons and Generates Primitive Oscillations
Physiol Rev, October 1, 2007; 87(4): 1215 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Kolarow, T. Brigadski, and V. Lessmann
Postsynaptic Secretion of BDNF and NT-3 from Hippocampal Neurons Depends on Calcium Calmodulin Kinase II Signaling and Proceeds via Delayed Fusion Pore Opening
J. Neurosci., September 26, 2007; 27(39): 10350 - 10364.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Wang, E. Bomberg, C. Billington, A. Levine, and C. M. Kotz
Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R992 - R1002.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. H. Mohajerani, S. Sivakumaran, P. Zacchi, P. Aguilera, and E. Cherubini
Correlated network activity enhances synaptic efficacy via BDNF and the ERK pathway at immature CA3 CA1 connections in the hippocampus
PNAS, August 7, 2007; 104(32): 13176 - 13181.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Wanaverbecq, A. Semyanov, I. Pavlov, M. C. Walker, and D. M. Kullmann
Cholinergic Axons Modulate GABAergic Signaling among Hippocampal Interneurons via Postsynaptic {alpha}7 Nicotinic Receptors
J. Neurosci., May 23, 2007; 27(21): 5683 - 5693.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. V. Caldeira, C. V. Melo, D. B. Pereira, R. Carvalho, S. S. Correia, D. S. Backos, A. L. Carvalho, J. A. Esteban, and C. B. Duarte
Brain-derived Neurotrophic Factor Regulates the Expression and Synaptic Delivery of{alpha}-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid Receptor Subunits in Hippocampal Neurons
J. Biol. Chem., April 27, 2007; 282(17): 12619 - 12628.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Lynch, E. A. Kramar, C. S. Rex, Y. Jia, D. Chappas, C. M. Gall, and D. A. Simmons
Brain-Derived Neurotrophic Factor Restores Synaptic Plasticity in a Knock-In Mouse Model of Huntington's Disease
J. Neurosci., April 18, 2007; 27(16): 4424 - 4434.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
J. O. McNamara, Y. Z. Huang, and A. S. Leonard
Molecular Signaling Mechanisms Underlying Epileptogenesis
Sci. Signal., October 10, 2006; 2006(356): re12 - re12.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Kanematsu, A. Yasunaga, Y. Mizoguchi, A. Kuratani, J. T. Kittler, J. N. Jovanovic, K. Takenaka, K. I. Nakayama, K. Fukami, T. Takenawa, et al.
Modulation of GABAA Receptor Phosphorylation and Membrane Trafficking by Phospholipase C-related Inactive Protein/Protein Phosphatase 1 and 2A Signaling Complex Underlying Brain-derived Neurotrophic Factor-dependent Regulation of GABAergic Inhibition
J. Biol. Chem., August 4, 2006; 281(31): 22180 - 22189.
[Abstract] [Full Text] [PDF]

Home page
 Behav Cogn Neurosci RevHome page
G. L. Dunbar, M. I. Sandstrom, J. Rossignol, and L. Lescaudron
Neurotrophic Enhancers as Therapy for Behavioral Deficits in Rodent Models of Huntington's Disease: Use of Gangliosides, Substituted Pyrimidines, and Mesenchymal Stem Cells.
Behav Cogn Neurosci Rev, June 1, 2006; 5(2): 63 - 79.
[Abstract] [PDF]

Home page
 J. Neurophysiol.Home page
S. A. Hewitt and J. S. Bains
Brain-Derived Neurotrophic Factor Silences GABA Synapses Onto Hypothalamic Neuroendocrine Cells Through a Postsynaptic Dynamin-Mediated Mechanism
J Neurophysiol, April 1, 2006; 95(4): 2193 - 2198.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
N. H. Woo and B. Lu
Regulation of Cortical Interneurons by Neurotrophins: From Development to Cognitive Disorders
Neuroscientist, February 1, 2006; 12(1): 43 - 56.
[Abstract] [PDF]

Home page
 NeuroscientistHome page
R. Koyama and Y. Ikegaya
To BDNF or Not to BDNF: That Is the Epileptic Hippocampus
Neuroscientist, August 1, 2005; 11(4): 282 - 287.
[Abstract] [PDF]

Home page
 J. Physiol.Home page
T. Yasui, S. Fujisawa, M. Tsukamoto, N. Matsuki, and Y. Ikegaya
Dynamic synapses as archives of synaptic history: state-dependent redistribution of synaptic efficacy in the rat hippocampal CA1
J. Physiol., July 1, 2005; 566(1): 143 - 160.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. Gubellini, Y. Ben-Ari, and J.-L. Gaiarsa
Endogenous Neurotrophins Are Required for the Induction of GABAergic Long-Term Potentiation in the Neonatal Rat Hippocampus
J. Neurosci., June 15, 2005; 25(24): 5796 - 5802.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
S. Ohba, T. Ikeda, Y. Ikegaya, N. Nishiyama, N. Matsuki, and M. K. Yamada
BDNF Locally Potentiates GABAergic Presynaptic Machineries: Target-selective Circuit Inhibition
Cereb Cortex, March 1, 2005; 15(3): 291 - 298.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
R. Blum and A. Konnerth
Neurotrophin-Mediated Rapid Signaling in the Central Nervous System: Mechanisms and Functions
Physiology, February 1, 2005; 20(1): 70 - 78.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Koyama, M. K. Yamada, S. Fujisawa, R. Katoh-Semba, N. Matsuki, and Y. Ikegaya
Brain-Derived Neurotrophic Factor Induces Hyperexcitable Reentrant Circuits in the Dentate Gyrus
J. Neurosci., August 18, 2004; 24(33): 7215 - 7224.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. A. Kramar, B. Lin, C.-Y. Lin, A. C. Arai, C. M. Gall, and G. Lynch
A Novel Mechanism for the Facilitation of Theta-Induced Long-Term Potentiation by Brain-Derived Neurotrophic Factor
J. Neurosci., June 2, 2004; 24(22): 5151 - 5161.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. L. Spires, H. E. Grote, N. K. Varshney, P. M. Cordery, A. van Dellen, C. Blakemore, and A. J. Hannan
Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism
J. Neurosci., March 3, 2004; 24(9): 2270 - 2276.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. N. Jovanovic, P. Thomas, J. T. Kittler, T. G. Smart, and S. J. Moss
Brain-Derived Neurotrophic Factor Modulates Fast Synaptic Inhibition by Regulating GABAA Receptor Phosphorylation, Activity, and Cell-Surface Stability
J. Neurosci., January 14, 2004; 24(2): 522 - 530.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. E. Scharfman, T. C. Mercurio, J. H. Goodman, M. A. Wilson, and N. J. MacLusky
Hippocampal Excitability Increases during the Estrous Cycle in the Rat: A Potential Role for Brain-Derived Neurotrophic Factor
J. Neurosci., December 17, 2003; 23(37): 11641 - 11652.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Mizoguchi, T. Kanematsu, M. Hirata, and J. Nabekura
A Rapid Increase in the Total Number of Cell Surface Functional GABAA Receptors Induced by Brain-derived Neurotrophic Factor in Rat Visual Cortex
J. Biol. Chem., November 7, 2003; 278(45): 44097 - 44102.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. A. Wardle and M.-m. Poo
Brain-Derived Neurotrophic Factor Modulation of GABAergic Synapses by Postsynaptic Regulation of Chloride Transport
J. Neurosci., September 24, 2003; 23(25): 8722 - 8732.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Kohara, A. Kitamura, N. Adachi, M. Nishida, C. Itami, S. Nakamura, and T. Tsumoto
Inhibitory But Not Excitatory Cortical Neurons Require Presynaptic Brain-Derived Neurotrophic Factor for Dendritic Development, as Revealed by Chimera Cell Culture
J. Neurosci., July 9, 2003; 23(14): 6123 - 6131.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
Y. Mizoguchi, H. Ishibashi, and J. Nabekura
The action of BDNF on GABAA currents changes from potentiating to suppressing during maturation of rat hippocampal CA1 pyramidal neurons
J. Physiol., May 1, 2003; 548(3): 703 - 709.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
Q. Cheng and H. H Yeh
Brain-derived neurotrophic factor attenuates mouse cerebellar granule cell GABAA receptor-mediated responses via postsynaptic mechanisms
J. Physiol., May 1, 2003; 548(3): 711 - 721.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Neal, J. Cunningham, I. Lever, S. Pezet, and M. Malcangio
Mechanism by which Brain-Derived Neurotrophic Factor Increases Dopamine Release from the Rabbit Retina
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 791 - 798.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
C. Rivera, H. Li, J. Thomas-Crusells, H. Lahtinen, T. Viitanen, A. Nanobashvili, Z. Kokaia, M. S. Airaksinen, J. Voipio, K. Kaila, et al.
BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion
J. Cell Biol., December 9, 2002; 159(5): 747 - 752.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
X.-P. He, L. Minichiello, R. Klein, and J. O. McNamara
Immunohistochemical Evidence of Seizure-Induced Activation of trkB Receptors in the Mossy Fiber Pathway of Adult Mouse Hippocampus
J. Neurosci., September 1, 2002; 22(17): 7502 - 7508.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. K. Yamada, K. Nakanishi, S. Ohba, T. Nakamura, Y. Ikegaya, N. Nishiyama, and N. Matsuki
Brain-Derived Neurotrophic Factor Promotes the Maturation of GABAergic Mechanisms in Cultured Hippocampal Neurons
J. Neurosci., September 1, 2002; 22(17): 7580 - 7585.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
C. Henneberger, R. Juttner, T. Rothe, and R. Grantyn
Postsynaptic Action of BDNF on GABAergic Synaptic Transmission in the Superficial Layers of the Mouse Superior Colliculus
J Neurophysiol, August 1, 2002; 88(2): 595 - 603.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
Y. Kovalchuk, E. Hanse, K. W. Kafitz, and A. Konnerth
Postsynaptic Induction of BDNF-Mediated Long-Term Potentiation
Science, March 1, 2002; 295(5560): 1729 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Canossa, E. Giordano, S. Cappello, C. Guarnieri, and S. Ferri
Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons
PNAS, February 20, 2002; (2002) 42504299.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. C. Gillespie, M. C. Crair, and M. P. Stryker
Neurotrophin-4/5 Alters Responses and Blocks the Effect of Monocular Deprivation in Cat Visual Cortex during the Critical Period
J. Neurosci., December 15, 2000; 20(24): 9174 - 9186.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. Du, L. Feng, F. Yang, and B. Lu
Activity- and Ca2+-dependent Modulation of Surface Expression of Brain-derived Neurotrophic Factor Receptors in Hippocampal Neurons
J. Cell Biol., September 18, 2000; 150(6): 1423 - 1434.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. Xu, W. Gottschalk, A. Chow, R. I. Wilson, E. Schnell, K. Zang, D. Wang, R. A. Nicoll, B. Lu, and L. F. Reichardt
The Role of Brain-Derived Neurotrophic Factor Receptors in the Mature Hippocampus: Modulation of Long-Term Potentiation through a Presynaptic Mechanism involving TrkB
J. Neurosci., September 15, 2000; 20(18): 6888 - 6897.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
N. Taniguchi, N. Takada, F. Kimura, and T. Tsumoto
Actions of brain-derived neurotrophic factor on evoked and spontaneous EPSCs dissociate with maturation of neurones cultured from rat visual cortex
J. Physiol., September 15, 2000; 527(3): 579 - 592.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F.-Q. Liang, G. Allen, and D. Earnest
Role of Brain-Derived Neurotrophic Factor in the Circadian Regulation of the Suprachiasmatic Pacemaker by Light
J. Neurosci., April 15, 2000; 20(8): 2978 - 2987.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
E. Kumura, F. Kimura, N. Taniguchi, and T. Tsumoto
Brain-derived neurotrophic factor blocks long-term depression in solitary neurones cultured from rat visual cortex
J. Physiol., April 1, 2000; 524(1): 195 - 204.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. Hamakawa, M. A. Woodin, M. C. Bjorgum, S. D. Painter, M. Takasaki, K. Lukowiak, G. T. Nagle, and N. I. Syed
Excitatory Synaptogenesis between Identified Lymnaea Neurons Requires Extrinsic Trophic Factors and Is Mediated by Receptor Tyrosine Kinases
J. Neurosci., November 1, 1999; 19(21): 9306 - 9312.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. T. Drake, T. A. Milner, and S. L. Patterson
Ultrastructural Localization of Full-Length trkB Immunoreactivity in Rat Hippocampus Suggests Multiple Roles in Modulating Activity-Dependent Synaptic Plasticity
J. Neurosci., September 15, 1999; 19(18): 8009 - 8026.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. T. Sherwood and D. C. Lo
Long-Term Enhancement of Central Synaptic Transmission by Chronic Brain-Derived Neurotrophic Factor Treatment
J. Neurosci., August 15, 1999; 19(16): 7025 - 7036.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Hashimoto, M. Fukaya, X. Qiao, K. Sakimura, M. Watanabe, and M. Kano
Impairment of AMPA Receptor Function in Cerebellar Granule Cells of Ataxic Mutant Mouse Stargazer
J. Neurosci., July 15, 1999; 19(14): 6027 - 6036.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. E. Scharfman, J. H. Goodman, and A. L. Sollas
Actions of Brain-Derived Neurotrophic Factor in Slices from Rats with Spontaneous Seizures and Mossy Fiber Sprouting in the Dentate Gyrus
J. Neurosci., July 1, 1999; 19(13): 5619 - 5631.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
X.-B. Gao and A N van den Pol
Neurotrophin-3 potentiates excitatory GABAergic synaptic transmission in cultured developing hypothalamic neurones of the rat
J. Physiol., July 1, 1999; 518(1): 81 - 95.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. D. Pozzo-Miller, W. Gottschalk, L. Zhang, K. McDermott, J. Du, R. Gopalakrishnan, C. Oho, Z.-H. Sheng, and B. Lu
Impairments in High-Frequency Transmission, Synaptic Vesicle Docking, and Synaptic Protein Distribution in the Hippocampus of BDNF Knockout Mice
J. Neurosci., June 15, 1999; 19(12): 4972 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. K. Binder, M. J. Routbort, and J. O. McNamara
Immunohistochemical Evidence of Seizure-Induced Activation of trk Receptors in the Mossy Fiber Pathway of Adult Rat Hippocampus
J. Neurosci., June 1, 1999; 19(11): 4616 - 4626.
[Abstract] [Full Text] [PDF]

Home page
 Learn. Mem.Home page
S. E. McKay, A. L. Purcell, and T. J. Carew
Regulation of Synaptic Function by Neurotrophic Factors in Vertebrates and Invertebrates: Implications for Development and Learning
Learn. Mem., May 1, 1999; 6(3): 193 - 215.
[Abstract] [Full Text]

Home page
 Learn. Mem.Home page
B. Berninger, A. F. Schinder, and M.-m. Poo
Synaptic Reliability Correlates with Reduced Susceptibility to Synaptic Potentiation by Brain-Derived Neurotrophic Factor
Learn. Mem., May 1, 1999; 6(3): 232 - 242.
[Abstract] [Full Text]

Home page
 Learn. Mem.Home page
W. A. Gottschalk, H. Jiang, N. Tartaglia, L. Feng, A. Figurov, and B. Lu
Signaling Mechanisms Mediating BDNF Modulation of Synaptic Plasticity in the Hippocampus
Learn. Mem., May 1, 1999; 6(3): 243 - 256.
[Abstract] [Full Text]

Home page
 Learn. Mem.Home page
R. A. Crozier, I. B. Black, and M. R. Plummer
Blockade of NR2B-Containing NMDA Receptors Prevents BDNF Enhancement of Glutamatergic Transmission in Hippocampal Neurons
Learn. Mem., May 1, 1999; 6(3): 257 - 266.
[Abstract] [Full Text]

Home page
 Learn. Mem.Home page
M. A. Woodin, T. Hamakawa, M. Takasaki, K. Lukowiak, and N. I. Syed
Trophic Factor-Induced Plasticity of Synaptic Connections Between Identified Lymnaea Neurons
Learn. Mem., May 1, 1999; 6(3): 307 - 316.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
S. Kinoshita, H. Yasuda, N. Taniguchi, R. Katoh-Semba, H. Hatanaka, and T. Tsumoto
Brain-Derived Neurotrophic Factor Prevents Low-Frequency Inputs from Inducing Long-Term Depression in the Developing Visual Cortex
J. Neurosci., March 15, 1999; 19(6): 2122 - 2130.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Narisawa-Saito, A. J. Silva, T. Yamaguchi, T. Hayashi, T. Yamamoto, and H. Nawa
Growth factor-mediated Fyn signaling regulates alpha -amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons
PNAS, March 2, 1999; 96(5): 2461 - 2466.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. K. Binder, M. J. Routbort, T. E. Ryan, G. D. Yancopoulos, and J. O. McNamara
Selective Inhibition of Kindling Development by Intraventricular Administration of TrkB Receptor Body
J. Neurosci., February 15, 1999; 19(4): 1424 - 1436.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Rage, B. Riteau, G. Alonso, and L. Tapia-Arancibia
Brain-Derived Neurotrophic Factor and Neurotrophin-3 Enhance Somatostatin Gene Expression through a Likely Direct Effect on Hypothalamic Somatostatin Neurons
Endocrinology, February 1, 1999; 140(2): 909 - 916.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
Y.-X. Li, Y. Zhang, H. A. Lester, E. M. Schuman, and N. Davidson
Enhancement of Neurotransmitter Release Induced by Brain-Derived Neurotrophic Factor in Cultured Hippocampal Neurons
J. Neurosci., December 15, 1998; 18(24): 10231 - 10240.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
M. Frerking, R. C. Malenka, and R. A. Nicoll
Brain-Derived Neurotrophic Factor (BDNF) Modulates Inhibitory, But Not Excitatory, Transmission in the CA1 Region of the Hippocampus
J Neurophysiol, December 1, 1998; 80(6): 3383 - 3386.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. Vicario-Abejon, C. Collin, R. D. G. McKay, and M. Segal
Neurotrophins Induce Formation of Functional Excitatory and Inhibitory Synapses between Cultured Hippocampal Neurons
J. Neurosci., September 15, 1998; 18(18): 7256 - 7271.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. Gottschalk, L. D. Pozzo-Miller, A. Figurov, and B. Lu
Presynaptic Modulation of Synaptic Transmission and Plasticity by Brain-Derived Neurotrophic Factor in the Developing Hippocampus
J. Neurosci., September 1, 1998; 18(17): 6830 - 6839.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
X. Qiao, L. Chen, H. Gao, S. Bao, F. Hefti, R. F. Thompson, and B. Knusel
Cerebellar Brain-Derived Neurotrophic Factor-TrkB Defect Associated with Impairment of Eyeblink Conditioning in Stargazer Mutant Mice
J. Neurosci., September 1, 1998; 18(17): 6990 - 6999.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. S. Levine, R. A. Crozier, I. B. Black, and M. R. Plummer
Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity
PNAS, August 18, 1998; 95(17): 10235 - 10239.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
E. Messaoudi, K. Bardsen, B. Srebro, and C. R. Bramham
Acute Intrahippocampal Infusion of BDNF Induces Lasting Potentiation of Synaptic Transmission in the Rat Dentate Gyrus
J Neurophysiol, January 1, 1998; 79(1): 496 - 499.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. T. Lockhart, G. G. Turrigiano, and S. J. Birren
Nerve Growth Factor Modulates Synaptic Transmission between Sympathetic Neurons and Cardiac Myocytes
J. Neurosci., December 15, 1997; 17(24): 9573 - 9582.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Canossa, O. Griesbeck, B. Berninger, G. Campana, R. Kolbeck, and H. Thoenen
Neurotrophin release by neurotrophins: Implications for activity-dependent neuronal plasticity
PNAS, November 25, 1997; 94(24): 13279 - 13286.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Y. Akaneya, T. Tsumoto, S. Kinoshita, and H. Hatanaka
Brain-Derived Neurotrophic Factor Enhances Long-Term Potentiation in Rat Visual Cortex
J. Neurosci., September 1, 1997; 17(17): 6707 - 6716.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Canossa, E. Giordano, S. Cappello, C. Guarnieri, and S. Ferri
Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons
PNAS, March 5, 2002; 99(5): 3282 - 3287.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Muller, Z. Djebbara-Hannas, P. Jourdain, L. Vutskits, P. Durbec, G. Rougon, and J. Z. Kiss
Brain-derived neurotrophic factor restores long-term potentiation in polysialic acid-neural cell adhesion molecule-deficient hippocampus
PNAS, April 11, 2000; 97(8): 4315 - 4320.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (192)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Matsuki, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Matsuki, N.

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-